EE244 Cost-Effectiveness Analysis of Liposomal Amphotericin B Versus Isavuconazole for Treating Mucormycosis in the Consolidation Phase from the Perspective of the Brazilian Unified Health System
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.545
https://www.valueinhealthjournal.com/article/S1098-3015(23)00645-9/fulltext
Title :
EE244 Cost-Effectiveness Analysis of Liposomal Amphotericin B Versus Isavuconazole for Treating Mucormycosis in the Consolidation Phase from the Perspective of the Brazilian Unified Health System
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00645-9&doi=10.1016/j.jval.2023.03.545
First page :
Section Title :
Open access? :
No
Section Order :
10029